EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design, Synthesis and Pharmacological Characterization of the First Photoswitchable Small-Molecule Agonist for the Atypical Chemokine Receptor 3

Sophie Bérenger, Justyna M Adamska, Francesca Deflorian, Chris de Graaf iD, Christie B Palmer, Martyna Szpakowska iD, Andy Chevigné iD, Iwan J P de Esch iD, Barbara Zarzycka iD, Henry F Vischer iD, Maikel Wijtmans iD, Rob Leurs iD

ACS Omega · 04.03.2025 · 10 (8) · 8675-8686

DOI: 10.1021/acsomega.4c11583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 18.02.2025. Verfasst von Sophie Bérenger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicinal Chemistry, Amsterdam Institute of Molecular and Life Sciences, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds National de la Recherche Luxembourg, H2020 Marie Sklodowska-Curie Actions, Luxembourg Institute of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Medicinal Chemistry, Amsterdam Institute of Molecular and Life Sciences, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands.
  • Nxera Pharma, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K.
  • Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, 29, rue Henri Koch, L-4354, Esch-sur-Alzette, Luxembourg; Faculty of Science, Technology and Medicine, Univers…
  • Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, 29, rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg.

ORCID-Profile: Chris de Graaf, Martyna Szpakowska, Andy Chevigné, Iwan J P de Esch, Barbara Zarzycka, Henry F Vischer, Maikel Wijtmans, Rob Leurs

Förderung

  • Fonds National de la Recherche Luxembourg
  • H2020 Marie Sklodowska-Curie Actions
  • Luxembourg Institute of Health
  • F.R.S.-FNRS-T?l?vie

Zitieren

APA

Bérenger, S., Adamska, J. M., Deflorian, F., de Graaf, C., Palmer, C. B., Szpakowska, M., Chevigné, A., de Esch, I. J. P., Zarzycka, B., Vischer, H. F., Wijtmans, M., & Leurs, R. (2025). Design, Synthesis and Pharmacological Characterization of the First Photoswitchable Small-Molecule Agonist for the Atypical Chemokine Receptor 3. ACS Omega, 10(8), 8675-8686. https://doi.org/10.1021/acsomega.4c11583

Vancouver

Bérenger S, Adamska JM, Deflorian F, de Graaf C, Palmer CB, Szpakowska M, et al. Design, Synthesis and Pharmacological Characterization of the First Photoswitchable Small-Molecule Agonist for the Atypical Chemokine Receptor 3. ACS Omega. 2025;10(8):8675-8686. doi:10.1021/acsomega.4c11583

BibTeX
@article{Brenger2025,
  author = {Bérenger, Sophie and Adamska, Justyna M and Deflorian, Francesca and de Graaf, Chris and Palmer, Christie B and Szpakowska, Martyna and Chevigné, Andy and de Esch, Iwan J P and Zarzycka, Barbara and Vischer, Henry F and Wijtmans, Maikel and Leurs, Rob},
  title = {Design, Synthesis and Pharmacological Characterization of the First Photoswitchable Small-Molecule Agonist for the Atypical Chemokine Receptor 3},
  journal = {ACS Omega},
  year = {2025},
  volume = {10},
  number = {8},
  pages = {8675--8686},
  doi = {10.1021/acsomega.4c11583}
}
Kostenlos starten →